Drug & supplement interaction

N,n-dmpea + Baricitinib

Baricitinib brand name: Olumiant.

No Known Interaction
The bottom line No known interaction

We found no known interaction between N,n-dmpea and Baricitinib in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first.

Know someone taking this? Share
Interaction report

N,n-dmpea and Baricitinib

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Baricitinib and N,n-dmpea in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

N,n-dmpea safety at a glance

N,n-dmpea overall Use caution Human safety data are very limited, and stimulant-like effects are possible.
Pregnancy Avoid No safety data exist, so it should be avoided during pregnancy.
Breastfeeding Avoid No safety data exist, so it should be avoided while breastfeeding.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Baricitinib and N,n-dmpea? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
How we checked

Why No Interaction Is Listed for Baricitinib

Interactions in our licensed database are recorded against drug classes, not just single drug names. Baricitinib is filed under 3 classifications — organic anion transporter 3 (oat3) substrates, hepatotoxic drugs, oral drugs. N,n-dmpea has documented interactions with 1 drug class — the most serious being cytochrome p450 2d6 (cyp2d6) substrates (moderate) — and none of Baricitinib’s classifications are among them.

Classification data comes from our licensed Natural Medicines dataset. A medication can belong to classes beyond those recorded there, so this describes how the check was run — it is not a safety guarantee.

Keep it in perspective

N,n-dmpea Does Interact With Other Medications

N,n-dmpea has 193 moderate known drug interactions in our database — Baricitinib isn’t one of them. If you take anything else, check it against the full list below.

Taking anything else?

Check Another of Your Medications Against N,n-dmpea

Covers the 2,830 medications we’ve checked against N,n-dmpea. Pick one to open its full report.

What to actually watch for

What Baricitinib’s Own FDA Label Lists

This is not an interaction — none of it involves N,n-dmpea. These are the most notable effects listed in the ADVERSE REACTIONS section of Baricitinib’s own FDA label, for the medication by itself. Knowing the drug’s own list makes it easier to work out the likely cause if something new turns up while you take both. 7 of them are worth acting on rather than waiting out — marked below.

  • Blood clots Worth acting on mentioned in 3.2% of FDA reports for Baricitinib
  • Low blood sugar Worth acting on
  • Anemia Worth acting on
  • A low white blood cell count Worth acting on
  • Liver problems Worth acting on
  • A higher chance of infection Worth acting on mentioned in 5.4% of FDA reports for Baricitinib
  • An allergic reaction Worth acting on
  • Acne
  • Hair loss
  • A stuffy or runny nose

Showing the 10 most notable of 16 label-listed effects — ranked by how unusual each one is across medicines generally, with serious effects weighted up.

From the ADVERSE REACTIONS section of the FDA label for Baricitinib. Read the label on DailyMed › Where a percentage is shown, it is the share of 9,585 voluntary FDA FAERS reports for Baricitinib that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. N,n-dmpea’s licensed record lists no adverse effects our clinical vocabulary could match, so there is no N,n-dmpea side to compare — that is a limit of the record, not a statement that N,n-dmpea has no side effects.

Everything else you take

See Every Supplement That Interacts With Baricitinib

This page covers N,n-dmpea only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Baricitinib page lists 59 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Activated Charcoal (major), Beer (major), Siberian Cocklebur (major), Wine (major) and African Wild Potato (moderate).

By severity: 4 major · 46 moderate · 9 minor.

From our pharmacist’s overview on the Baricitinib page

“Liver strain dominates this page. Baricitinib (Olumiant), a JAK inhibitor for rheumatoid arthritis and alopecia areata, can raise liver enzymes on its own, so I'd approach these combinations warily, since nearly two thirds of the listed supplements carry their own record of liver injury, and ordinary beer and wine sit among the highest…”

Reviewed by 2 · Jul 18, 2026

Open the Baricitinib interaction page

How much people look this up

Where N,n-dmpea and Baricitinib Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement N,n-dmpea
Steady interest

#1,245 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Baricitinib
Steady interest

#1,489 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every N,n-dmpea reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 20, 2026. The N,n-dmpea and Baricitinib records this page draws on were last updated June 22, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About N,n-dmpea

What is N,n-dmpea?

  • Mood or energy support
  • Pre-workout or stimulant effect
  • Cognitive or focus support

N,N-DMPEA (N,N-dimethylphenethylamine) is a synthetic relative of phenethylamine sometimes marketed in stimulant or pre-workout supplements. There is very little reliable human research on its effects or safety, and it is not a well-established dietary ingredient, so it should be approached with real caution.

Powder, capsules, research chemical

An interaction check asks whether these two react with each other — it does not ask whether N,n-dmpea is a good idea for someone in your situation. Here is what our N,n-dmpea record says about it on its own.

N,n-dmpea: dosing

There is no established or standardized safe dose of N,N-DMPEA. Because it has not been properly studied in humans, no reliable dosing guidance exists.If a product contains it, follow the product label, but understand that label amounts may not be accurate or safe.

From our N,n-dmpea monograph — the full record covers uses, side effects and every documented interaction.

Read the full N,n-dmpea monograph & all interactions
Medication

About Baricitinib

What Is Baricitinib Used For?

Brand name: Olumiant

Olumiant (baricitinib) tablets are approved for three conditions in adults. It treats moderately to severely active rheumatoid arthritis in people who haven't responded well enough to one or more TNF blocker medications. It also treats severe alopecia areata (significant hair loss from an autoimmune condition).

Olumiant is additionally approved to treat COVID-19 in hospitalized adults who need supplemental oxygen, mechanical ventilation, or ECMO (a machine that does the work of the heart and lungs). Each use has specific limitations — for example, Olumiant should not be combined with other JAK inhibitors or certain strong immunosuppressants for rheumatoid arthritis or alopecia areata.

Most-Reported Side Effects for Baricitinib

From FAERS, the FDA’s public side-effect reporting system (9,585 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Covid-19 449 reports
Rheumatoid arthritis 355 reports
Pulmonary embolism 309 reports
Pneumonia 282 reports
Headache 265 reports
See full Baricitinib drug information
Keep checking

Other Drugs & N,n-dmpea

Browse every other medication we’ve checked against N,n-dmpea — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
193Moderate
0Minor
2,636No known interaction
Moderate

193 interactions

Showing 60 of 193 moderate interactions — see all 193 on the N,n-dmpea page.

No interaction 2,636 drugs checked — show the list
Evidence & sources

N,n-dmpea References

The 2 references that drive our N,n-dmpea monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Liu Y, Santillo MF. Cytochrome P450 2D6 and 3A4 enzyme inhibition by amine stimulants in dietary supplements. Drug Test Anal. 2016;8(3-4):307-10. PubMed
  2. Schoenwald RD, Vidvauns S, Wurster DE, Barfknecht CF. Tear film stability of protein extracts from dry eye patients administered a sigma agonist. J Ocul Pharmacol Ther 1997;13(2):151-61. PubMed

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking N,n-dmpea and Baricitinib Together: Common Questions

Is it safe to take N,n-dmpea with Baricitinib?
We do not list a known interaction between N,n-dmpea and Baricitinib. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
How was the N,n-dmpea and Baricitinib combination checked?
Interactions in our licensed database are recorded against drug classes. Baricitinib is filed under 3 classifications, and N,n-dmpea has documented interactions with 1 drug class — none of Baricitinib's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Does N,n-dmpea interact with any other medications?
Yes. N,n-dmpea has 193 documented drug interactions in our database — Baricitinib is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does Baricitinib interact with any supplements?
Yes. Baricitinib has documented interactions with 59 supplements in our database — N,n-dmpea is not one of them. The Baricitinib interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Baricitinib and N,n-dmpea?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.